Risk Factors of Catheter-Related Thrombosis in Elderly Patients with Lung Cancer Based on Thromboelastography: A Retrospective, Case-Control Study.

IF 4.1 2区 医学 Q2 HEMATOLOGY
Jiaji Hu, Binbin Xu, Nian Yao, Sha Peng, Jiaxin Lv, Haixia Yu, Jianmei Hou, Zhengkun Shi, Jianan Wang, Xin Huang, Guiyuan Ma, Jinghui Zhang
{"title":"Risk Factors of Catheter-Related Thrombosis in Elderly Patients with Lung Cancer Based on Thromboelastography: A Retrospective, Case-Control Study.","authors":"Jiaji Hu, Binbin Xu, Nian Yao, Sha Peng, Jiaxin Lv, Haixia Yu, Jianmei Hou, Zhengkun Shi, Jianan Wang, Xin Huang, Guiyuan Ma, Jinghui Zhang","doi":"10.1055/a-2576-4895","DOIUrl":null,"url":null,"abstract":"<p><p>Catheter-related thrombosis (CRT) poses serious risks for cancer patients. Identifying risk factors and implementing targeted interventions can prevent CRT. To explore thromboelastogram parameters and clinical risk factors for CRT in elderly lung cancer patients. A total of 663 elderly lung cancer patients were selected from three hospitals in Hunan, Hainan, and Qinghai provinces in China from January 1, 2022, to June 30, 2024. The patients were divided into two groups: a CRT group (221 patients) and a non-CRT group (442 patients), with a ratio of 1:2. A between-group comparison and binary logistic regression were used to analyze risk factors for CRT in elderly lung cancer patients. Binary logistic regression analysis showed that decreased <i>R</i> (odds ratio [OR]: 0.849, 95% confidence interval [CI]: 0.763-0.945, <i>p</i> = 0.003), decreased <i>K</i> (0.571, 95% CI: 0.404-0.807, <i>p</i> = 0.001), advanced age (OR: 1.073, 95% CI: 1.033-1.113, <i>p</i> < 0.001), elevated platelet count (OR: 1.006, 95% CI: 1.004-1.009, <i>p</i> < 0.001), increased hemoglobin level (OR: 1.020, 95% CI: 1.009-1.031, <i>p</i> < 0.001), shortened PT (OR: 0.904, 95% CI: 0.830-0.985, <i>p</i> = 0.022), surgery ≤ 1 month (OR: 2.258, 95% CI: 1.420-3.590, <i>p</i> = 0.001), male sex (OR: 4.534, 95% CI: 2.815-7.304, <i>p</i> < 0.001), diabetes (OR: 2.478, 95% CI: 1.373-4.472, <i>p</i> = 0.003), hypertension (OR: 2.386, 95% CI: 1.505-3.784, <i>p</i> < 0.001), physical activity disorders (OR: 9.038, 95% CI: 4.462-18.309, <i>p</i> < 0.001) were independent risk factors for CRT in elderly lung cancer patients. Independent risk factors for CRT in elderly lung cancer patients include decreased <i>K</i>-values and decreased <i>R</i>-values, shortened PT, advanced age, elevated platelet count, increased hemoglobin level, surgery ≤ 1 month, male sex, diabetes, hypertension, and physical activity disorders.</p>","PeriodicalId":21673,"journal":{"name":"Seminars in thrombosis and hemostasis","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in thrombosis and hemostasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2576-4895","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Catheter-related thrombosis (CRT) poses serious risks for cancer patients. Identifying risk factors and implementing targeted interventions can prevent CRT. To explore thromboelastogram parameters and clinical risk factors for CRT in elderly lung cancer patients. A total of 663 elderly lung cancer patients were selected from three hospitals in Hunan, Hainan, and Qinghai provinces in China from January 1, 2022, to June 30, 2024. The patients were divided into two groups: a CRT group (221 patients) and a non-CRT group (442 patients), with a ratio of 1:2. A between-group comparison and binary logistic regression were used to analyze risk factors for CRT in elderly lung cancer patients. Binary logistic regression analysis showed that decreased R (odds ratio [OR]: 0.849, 95% confidence interval [CI]: 0.763-0.945, p = 0.003), decreased K (0.571, 95% CI: 0.404-0.807, p = 0.001), advanced age (OR: 1.073, 95% CI: 1.033-1.113, p < 0.001), elevated platelet count (OR: 1.006, 95% CI: 1.004-1.009, p < 0.001), increased hemoglobin level (OR: 1.020, 95% CI: 1.009-1.031, p < 0.001), shortened PT (OR: 0.904, 95% CI: 0.830-0.985, p = 0.022), surgery ≤ 1 month (OR: 2.258, 95% CI: 1.420-3.590, p = 0.001), male sex (OR: 4.534, 95% CI: 2.815-7.304, p < 0.001), diabetes (OR: 2.478, 95% CI: 1.373-4.472, p = 0.003), hypertension (OR: 2.386, 95% CI: 1.505-3.784, p < 0.001), physical activity disorders (OR: 9.038, 95% CI: 4.462-18.309, p < 0.001) were independent risk factors for CRT in elderly lung cancer patients. Independent risk factors for CRT in elderly lung cancer patients include decreased K-values and decreased R-values, shortened PT, advanced age, elevated platelet count, increased hemoglobin level, surgery ≤ 1 month, male sex, diabetes, hypertension, and physical activity disorders.

基于血栓弹性成像的老年肺癌患者导管相关血栓形成的危险因素:回顾性病例对照研究。
导管相关血栓形成(CRT)对癌症患者具有严重的风险。识别危险因素并实施有针对性的干预措施可以预防CRT。探讨老年肺癌患者CRT的血栓弹性图参数及临床危险因素。从2022年1月1日至2024年6月30日,从中国湖南、海南和青海三省的三家医院共选择了663名老年肺癌患者。将患者分为两组:CRT组(221例)和非CRT组(442例),比例为1:2。采用组间比较和二元logistic回归分析老年肺癌患者行CRT的危险因素。二元logistic回归分析显示,R降低(比值比[OR]: 0.849, 95%可信区间[CI]: 0.763-0.945, p = 0.003), K降低(0.571,95% CI: 0.404-0.807, p = 0.001),高龄(OR: 1.073, 95% CI: 1.033-1.113, p p p = 0.022),手术≤1个月(OR: 2.258, 95% CI: 1.420-3.590, p = 0.001),男性(OR: 4.534, 95% CI: 2.815-7.304, p p = 0.003),高血压(OR: 2.386, 95% CI:1.505-3.784, p p k值和r值降低,PT缩短,高龄,血小板计数升高,血红蛋白水平升高,手术≤1个月,男性,糖尿病,高血压,身体活动障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Seminars in thrombosis and hemostasis
Seminars in thrombosis and hemostasis 医学-外周血管病
CiteScore
8.80
自引率
21.10%
发文量
132
审稿时长
6-12 weeks
期刊介绍: Seminars in Thrombosis and Hemostasis is a topic driven review journal that focuses on all issues relating to hemostatic and thrombotic disorders. As one of the premiere review journals in the field, Seminars in Thrombosis and Hemostasis serves as a comprehensive forum for important advances in clinical and laboratory diagnosis and therapeutic interventions. The journal also publishes peer reviewed original research papers. Seminars offers an informed perspective on today''s pivotal issues, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques. The journal also frequently publishes sponsored supplements to further highlight emerging trends in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信